BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26536249)

  • 1. Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives.
    Brenca M; Maestro R
    Expert Rev Anticancer Ther; 2015; 15(12):1473-88. PubMed ID: 26536249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
    Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
    Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ChildSeq-RNA: A next-generation sequencing-based diagnostic assay to identify known fusion transcripts in childhood sarcomas.
    Qadir MA; Zhan SH; Kwok B; Bruestle J; Drees B; Popescu OE; Sorensen PH
    J Mol Diagn; 2014 May; 16(3):361-70. PubMed ID: 24517889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current updates in sarcoma biomarker discovery: emphasis on next-generation sequencing-based methods.
    Patton A; Dermawan JK
    Pathology; 2024 Mar; 56(2):274-282. PubMed ID: 38185613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours.
    Dufresne A; Brahmi M; Karanian M; Blay JY
    Nat Rev Clin Oncol; 2018 Jul; 15(7):443-458. PubMed ID: 29666441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in sarcoma molecular diagnostics.
    Wang XQ; Goytain A; Dickson BC; Nielsen TO
    Genes Chromosomes Cancer; 2022 Jun; 61(6):332-345. PubMed ID: 35064596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
    Marino-Enriquez A
    Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing and its applications in molecular diagnostics.
    Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
    Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing technologies for environmental DNA research.
    Shokralla S; Spall JL; Gibson JF; Hajibabaei M
    Mol Ecol; 2012 Apr; 21(8):1794-805. PubMed ID: 22486820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soft tissue sarcomas--new approaches to diagnosis and classification.
    Lauer S; Gardner JM
    Curr Probl Cancer; 2013; 37(2):45-61. PubMed ID: 23719330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-mediated gene regulations in human sarcomas.
    Subramanian S; Kartha RV
    Cell Mol Life Sci; 2012 Nov; 69(21):3571-85. PubMed ID: 22922987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
    Baumhoer D; Amary F; Flanagan AM
    Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing - feasibility and practicality in haematology.
    Kohlmann A; Grossmann V; Nadarajah N; Haferlach T
    Br J Haematol; 2013 Mar; 160(6):736-53. PubMed ID: 23294427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
    Lesluyes T; Pérot G; Largeau MR; Brulard C; Lagarde P; Dapremont V; Lucchesi C; Neuville A; Terrier P; Vince-Ranchère D; Mendez-Lago M; Gut M; Gut I; Coindre JM; Chibon F
    Eur J Cancer; 2016 Apr; 57():104-11. PubMed ID: 26916546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
    Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
    Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive parallel sequencing of solid tumours - challenges and opportunities for pathologists.
    Harris G; O'Toole S; George P; Browett P; Print C
    Histopathology; 2017 Jan; 70(1):123-133. PubMed ID: 27556576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of an EWSR1-POU5F1 fusion associated with a t(6;22) in an undifferentiated soft tissue sarcoma.
    Deng FM; Galvan K; de la Roza G; Zhang S; Souid AK; Stein CK
    Cancer Genet; 2011 Aug; 204(8):423-9. PubMed ID: 21962892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of new high-throughput technologies for diagnosis and prognosis in solid tumors.
    Pinto R; De Summa S; Petriella D; Tudoran O; Danza K; Tommasi S
    Cancer Biomark; 2014; 14(2-3):103-17. PubMed ID: 24878811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.